Please login to the form below

Not currently logged in
Email:
Password:

ABPI appoints value and access director

Paul Catchpole joins ABPI to promote the value of the industry and improve access to medicines

Paul Catchpole has joined the Association of the British Pharmaceutical Industry (ABPI) to drive the association's work in demonstrating the value of the industry and improving patients' access to innovative medicines.

He joins the association with 26 years' industry experience, most recently as healthcare management director at Roche UK. Paul has been an active member of various ABPI working groups and was also involved in the last two Pharmaceutical Price Regulation Scheme (PPRS) negotiations, influencing the design of patient access and flexible pricing schemes.

Commenting on this new role, Paul said: "I am delighted to be taking up this role at such an important and challenging time for the pharmaceutical industry. The unprecedented economic pressures facing our healthcare system, along with potential political changes, means that the need has never been greater for the industry to be clear about all aspects of value that our medicines bring to patients and the NHS and how these can be evaluated.

"Providing greater and faster access for patients also remains a key challenge and an opportunity where innovative medicines can drive further quality and productivity improvements through strong partnership working with NHS organisations," he added.

Paul takes up his new post on April 26.

19th April 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Apex.co.uk Conferences, Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading event and exhibition agencies, specialising in healthcare. We understand your communication goals, whether...

Latest intelligence

Mobilising the public to combat the antimicrobial resistance crisis
Antimicrobial resistance is one of the greatest threats to human health, according to the World Health Organisation. So why doesn’t the public seem bothered? BLH Account Executive Ford Stewart examines...
Measures for measures
Why pharma’s marketing metrics must close the loop...
Where next in Alzheimer’s disease R&D?
How past failures and emerging biology are reshaping drug development...

Infographics